Impact of Left Ventricular Venting on Acute Brain Injury in Patients With Cardiogenic Shock: An Extracorporeal Life Support Organization Registry Analysis.
Shi Nan Feng, Winnie L Liu, Jin Kook Kang, Andrew Kalra, Jiah Kim, Akram Zaqooq, Melissa A Vogelsong, Bo Soo Kim, Daniel Brodie, Patricia Brown, Glenn J R Whitman, Steven Keller, Sung-Min Cho
{"title":"Impact of Left Ventricular Venting on Acute Brain Injury in Patients With Cardiogenic Shock: An Extracorporeal Life Support Organization Registry Analysis.","authors":"Shi Nan Feng, Winnie L Liu, Jin Kook Kang, Andrew Kalra, Jiah Kim, Akram Zaqooq, Melissa A Vogelsong, Bo Soo Kim, Daniel Brodie, Patricia Brown, Glenn J R Whitman, Steven Keller, Sung-Min Cho","doi":"10.1097/CCM.0000000000006897","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>While left ventricular (LV) venting reduces LV distension in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation (ECMO), it may also amplify risk of acute brain injury (ABI). We investigated the hypothesis that LV venting is associated with increased risk of ABI. We also compared ABI risk of the two most common LV venting strategies, percutaneous microaxial flow pump (mAFP) and intra-aortic balloon pump (IABP).</p><p><strong>Design: </strong>Retrospective observational cohort study.</p><p><strong>Setting: </strong>The Extracorporeal Life Support Organization registry.</p><p><strong>Patients: </strong>Adult patients on peripheral venoarterial ECMO for cardiogenic shock (2013-2024).</p><p><strong>Interventions: </strong>None.</p><p><strong>Measurements and main results: </strong>ABI was defined as hypoxic-ischemic brain injury, ischemic stroke, or intracranial hemorrhage. Secondary outcome was hospital mortality. We compared no LV venting with: 1) LV venting, 2) mAFP, and 3) IABP using multivariable logistic regression. To compare ABI risk of mAFP vs. IABP, propensity-score matching was performed. Of 13,276 patients (median age = 58.2, 69.9% male), 1,456 (11.0%) received LV venting (65.5% mAFP and 29.9% IABP), and 525 (4.0%) had ABI. After multivariable regression, LV-vented patients had increased odds of ABI (adjusted odds ratio [aOR], 1.67; 95% CI, 1.22-2.26; p = 0.001) but no difference in mortality (aOR, 1.07; 95% CI, 0.90-1.27; p = 0.45) compared with non-LV-vented patients. In the propensity-matched cohort of IABP (n = 231) vs. mAFP (n = 231) patients, there was no significant difference in odds of ABI (aOR, 1.35; 95% CI, 0.69-2.71; p = 0.39) or mortality (aOR, 0.88; 95% CI, 0.58-1.31; p = 0.52).</p><p><strong>Conclusions: </strong>LV venting was associated with increased odds of ABI but not mortality in patients receiving peripheral venoarterial ECMO for cardiogenic shock. There was no difference in odds of ABI or mortality for IABP vs. mAFP patients.</p>","PeriodicalId":10765,"journal":{"name":"Critical Care Medicine","volume":" ","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/CCM.0000000000006897","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: While left ventricular (LV) venting reduces LV distension in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation (ECMO), it may also amplify risk of acute brain injury (ABI). We investigated the hypothesis that LV venting is associated with increased risk of ABI. We also compared ABI risk of the two most common LV venting strategies, percutaneous microaxial flow pump (mAFP) and intra-aortic balloon pump (IABP).
Design: Retrospective observational cohort study.
Setting: The Extracorporeal Life Support Organization registry.
Patients: Adult patients on peripheral venoarterial ECMO for cardiogenic shock (2013-2024).
Interventions: None.
Measurements and main results: ABI was defined as hypoxic-ischemic brain injury, ischemic stroke, or intracranial hemorrhage. Secondary outcome was hospital mortality. We compared no LV venting with: 1) LV venting, 2) mAFP, and 3) IABP using multivariable logistic regression. To compare ABI risk of mAFP vs. IABP, propensity-score matching was performed. Of 13,276 patients (median age = 58.2, 69.9% male), 1,456 (11.0%) received LV venting (65.5% mAFP and 29.9% IABP), and 525 (4.0%) had ABI. After multivariable regression, LV-vented patients had increased odds of ABI (adjusted odds ratio [aOR], 1.67; 95% CI, 1.22-2.26; p = 0.001) but no difference in mortality (aOR, 1.07; 95% CI, 0.90-1.27; p = 0.45) compared with non-LV-vented patients. In the propensity-matched cohort of IABP (n = 231) vs. mAFP (n = 231) patients, there was no significant difference in odds of ABI (aOR, 1.35; 95% CI, 0.69-2.71; p = 0.39) or mortality (aOR, 0.88; 95% CI, 0.58-1.31; p = 0.52).
Conclusions: LV venting was associated with increased odds of ABI but not mortality in patients receiving peripheral venoarterial ECMO for cardiogenic shock. There was no difference in odds of ABI or mortality for IABP vs. mAFP patients.
期刊介绍：
Critical Care Medicine is the premier peer-reviewed, scientific publication in critical care medicine. Directed to those specialists who treat patients in the ICU and CCU, including chest physicians, surgeons, pediatricians, pharmacists/pharmacologists, anesthesiologists, critical care nurses, and other healthcare professionals, Critical Care Medicine covers all aspects of acute and emergency care for the critically ill or injured patient.
Each issue presents critical care practitioners with clinical breakthroughs that lead to better patient care, the latest news on promising research, and advances in equipment and techniques.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
